Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential - Zhang, Yukun; Lu, Peng; Qin, Huan; Zhang, Yuelin; Sun, Xinru; Song, Xunan; Liu, Jingjing; Peng, Hui; Liu, Yiting; Nwafor, Ebuka Olisaemeka; Li, Jiawei; Liu, Zhidong (Biomedicine & pharmacotherapy, 2021)
Keywords: COVID-19; COVID-19 - complications; Drug Compounding; Drugs, Chinese Herbal - administration & dosage; Drugs, Chinese Herbal - chemistry; Drugs, Chinese Herbal - therapeutic use; History, 15th Century; History, 16th Century; History, 17th Century; History, 18th Century; History, 19th Century; History, 20th Century; History, Ancient; History, Medieval; Humans; Idiopathic pulmonary fibrosis; Idiopathic Pulmonary Fibrosis - drug therapy; Idiopathic Pulmonary Fibrosis - etiology; Idiopathic Pulmonary Fibrosis - prevention & control; Medicine, Chinese Traditional - history; Medicine, Chinese Traditional - methods; Nebulizers and Vaporizers; Phytotherapy; Pulmonary drug delivery system; Respiratory Therapy; Traditional Chinese medicine; LN; TIMP-1; JNK; AKt; MDA; INF-γ; COVID-19; α-SMA; MDI; PI3K; QE; HELF; CUR; FGF; PDDS; ANG-(1-7); MAPK; EMT; IL-6; MMP; TGF; SAB; HSP-47; DPI; TCM; ERK; HLF; Col III; Idiopathic pulmonary fibrosis; LPO; Pulmonary drug delivery system; S1P; Nrf2; SphK1; GA; GSH; HYP; HSP90; ASV; PMDI; VASH; Traditional Chinese medicine; NEB; ECM; Smad3; TNF-α; PDGF; NOX4; HA; FOXO3a; ACE-2; IPF